ArticleJournal of medical case reports2022

Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report.

Bai-Yan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.